1. Short title This Act may be cited as the FDA Reporting Transparency and Accountability Act . 2. Streamlining and improving consistency in performance reporting (a) PDUFA Section 736B(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379h–2(a) ) is amended— (1) in paragraph (1)(B)— (A) in each of clauses (i), (ii), and (v), by inserting and the number of complete response letters issued for such applications before the semicolon; (B) in each of clauses (iii) and (iv), by inserting and the number of complete response letters issued for such supplements before the semicolon; (C) in clause (vi), by inserting and the number of designations and denials issued by the agency for such applications before the semicolon; (D) in clause (vii), by striking ; and and inserting and the number of designations and denials issued by the agency for such applications; ; and (E) in clause (viii) by striking the period and inserting and the number of designations and denials issued by the agency for such applications;